We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

149 hedge funds and large institutions have $1.65B invested in IVERIC bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 62 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more capital invested

Capital invested by funds: $536M → $1.65B (+$1.12B)

117% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 18

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

100% more call options, than puts

Call options by funds: $55.9M | Put options by funds: $28M

94% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 32

16% more funds holding

Funds holding: 128 → 149 (+21)

Holders
149
Holders Change
+21
Holders Change %
+16.41%
% of All Funds
2.61%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
39
Increased
62
Reduced
32
Closed
18
Calls
$55.9M
Puts
$28M
Net Calls
+$27.9M
Net Calls Change
+$26.4M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$31.9M
2
PA
Perceptive Advisors
New York
+$31.4M
3
APM
Avidity Partners Management
Texas
+$29.4M
4
Invesco
Invesco
Georgia
+$22.7M
5
PCH
Polar Capital Holdings
United Kingdom
+$16.8M

Top Sellers

1
SCM
Soleus Capital Management
Connecticut
-$18.7M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$16.1M
3
LGM
Logos Global Management
California
-$15.8M
4
DM
Deerfield Management
New York
-$9.83M
5
BBA
Baker Bros. Advisors
New York
-$8.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$126M +$11.1M +1,016,533 +15%
PA
2
Perceptive Advisors
New York
$121M +$31.4M +2,886,286 +63%
ACA
3
Avoro Capital Advisors
New York
$115M +$7.35M +675,000 +11%
RI
4
RTW Investments
New York
$109M – – –
VC
5
Vivo Capital
California
$96.9M – – –
YCM
6
Yiheng Capital Management
California
$82.2M +$33.7K +3,100 +0.1%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$80.9M +$31.9M +2,926,658 +143%
DM
8
Deerfield Management
New York
$79M -$9.83M -903,684 -16%
Vanguard Group
9
Vanguard Group
Pennsylvania
$79M +$7.22M +663,864 +16%
State Street
10
State Street
Massachusetts
$77M +$16.7M +1,533,832 +48%
APM
11
Avidity Partners Management
Texas
$66.6M +$29.4M +2,699,990 +193%
CC
12
Commodore Capital
New York
$44.7M +$10.9M +1,001,896 +57%
Invesco
13
Invesco
Georgia
$34.4M +$22.7M +2,082,326 +6,277%
FM
14
Frazier Management
Washington
$29.9M -$7.68M -706,098 -28%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$26.6M +$2.06M +189,008 +13%
Two Sigma Investments
16
Two Sigma Investments
New York
$24.8M +$13.4M +1,230,217 +416%
SB
17
Samsara BioCapital
California
$23.8M -$7.21M -662,537 -31%
CS
18
Candriam SCA
Luxembourg
$19.7M +$5.87M +539,697 +80%
PHS
19
PFM Health Sciences
California
$18.5M +$12.4M +1,138,112 New
ACP
20
Acuta Capital Partners
California
$18.4M -$1.25M -115,000 -9%
Ameriprise
21
Ameriprise
Minnesota
$17.9M +$72.8K +6,686 +0.6%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$17.8M +$6.06M +557,211 +103%
SCM
23
Soleus Capital Management
Connecticut
$17.8M -$18.7M -1,715,323 -61%
Northern Trust
24
Northern Trust
Illinois
$15.8M +$1.2M +109,918 +13%
DCM
25
Driehaus Capital Management
Illinois
$15.1M +$10.1M +932,432 New
1
2 3 4 5

ISEE Hedge Fund Activity: Q3 2021 in Review

149 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2021, worth a combined $1.65B — up 208% from $536M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ISEE positions and 18 closed out — a net gain of 21 holders — while 62 added to existing stakes and 32 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $31.9M. The largest seller was Soleus Capital Management, cutting an estimated $18.7M.

  • 149 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2021, up from 128 in Q2 2021.
  • Funds reported $1.65B of IVERIC bio, Inc. Common Stock stock for Q3 2021, up 208% quarter-over-quarter.
  • 39 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2021 and 18 closed out, a net change of +21 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q3 2021 was T. Rowe Price Associates, an estimated $31.9M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q3 2021 was Soleus Capital Management, an estimated $18.7M sold.

Based on aggregated 13F filings for Q3 2021.